CytoSorbents Corp (CTSO)

1.06 -0.08 (-7.02%) USD  |  NASDAQ  |  Jul 11, 16:00
1.07 +0.01 (+0.94%) After-Hours: 20:00
More

CytoSorbents Debt to Equity Ratio: 0.9755 for March 31, 2025

Debt to Equity Ratio Chart

View Debt to Equity Ratio for CTSO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Delcath Systems Inc 0.00
Star Equity Holdings Inc 0.2254
Exact Sciences Corp 0.969
Illumina Inc 0.8404
Natera Inc 0.0648

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 50.78M
Total Liabilities (Quarterly) 36.24M
Shareholders Equity (Quarterly) 14.54M
Current Ratio 2.610
Net Debt Paydown Yield -2.92%